Literature DB >> 2337296

Type VIII collagen in murine development. Association with capillary formation in vitro.

H Sage1, M L Iruela-Arispe.   

Abstract

Bovine endothelial and human astrocytoma cells, and a limited number of other normal and malignant cells, synthesize three chains that have been identified as type VIII collagen (180 kDa, 125 kDa, and 100 kDa). Digestion with pepsin converts these forms to major fragments of 65 kD (based on globular protein standards). In this study we have examined the structure and distribution of type VIII collagen in developing mice by immunohistological and immunoblotting techniques. Temporal and tissue-specific expression was observed in embryonic heart, cranial mesenchyme, and placental capillaries. Western blotting of embryonic and neonatal tissues showed major species of 125 and 65 kDa in the brain, placenta, heart, lung, and thymus. The predominant band in pepsin-treated tissues was 60-70 kDa, with additional forms of 250 and 150 kDa in neonatal heart and lung. Type VIII collagen was also synthesized by endothelial cells, forming capillary tubes in vitro. We suggest that type VIII collagen functions in cellular organization and differentiation, and that its various forms reflect not only tissue-specific processing but the presence of several related chains.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337296     DOI: 10.1111/j.1749-6632.1990.tb17914.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair.

Authors:  G Hou; W Vogel; M P Bendeck
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury.

Authors:  G Hou; D Mulholland; M A Gronska; M P Bendeck
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

3.  Upregulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis.

Authors:  S Sinha; C M Kielty; A M Heagerty; A E Canfield; C A Shuttleworth
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

Review 4.  Molecular bases of corneal endothelial dystrophies.

Authors:  Thore Schmedt; Mariana Mazzini Silva; Alireza Ziaei; Ula Jurkunas
Journal:  Exp Eye Res       Date:  2011-08-10       Impact factor: 3.467

5.  Type VIII collagen is a product of vascular smooth-muscle cells in development and disease.

Authors:  J R MacBeath; C M Kielty; C A Shuttleworth
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

6.  Mast cells and type VIII collagen in human diabetic nephropathy.

Authors:  B M Rüger; Q Hasan; N S Greenhill; P F Davis; P R Dunbar; T J Neale
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

7.  Human mast cells produce type VIII collagen in vivo.

Authors:  B Rüger; P R Dunbar; Q Hasan; H Sawada; R Kittelberger; N Greenhill; T J Neale
Journal:  Int J Exp Pathol       Date:  1994-12       Impact factor: 1.925

8.  Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model.

Authors:  Matthew R Steinhart; Frances E Cone; Cathy Nguyen; Thao D Nguyen; Mary E Pease; Oliver Puk; Jochen Graw; Ericka N Oglesby; Harry A Quigley
Journal:  Mol Vis       Date:  2012-05-01       Impact factor: 2.367

9.  Increased levels of type VIII collagen in human brain tumours compared to normal brain tissue and non-neoplastic cerebral disorders.

Authors:  W Paulus; E H Sage; U Liszka; M L Iruela-Arispe; K Jellinger
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

10.  Age-Related Differential Structural and Transcriptomic Responses in the Hypertensive Heart.

Authors:  Francine Z Marques; Po-Yin Chu; Mark Ziemann; Antony Kaspi; Helen Kiriazis; Xiao-Jun Du; Assam El-Osta; David M Kaye
Journal:  Front Physiol       Date:  2018-07-09       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.